Literature DB >> 18385442

Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates.

Wen-Chien Ko1, Nan-Yao Lee, Siou Cing Su, Lenie Dijkshoorn, Mario Vaneechoutte, Li-Rong Wang, Jin-Jou Yan, Tsung Chain Chang.   

Abstract

Acinetobacter calcoaceticus, A. baumannii, Acinetobacter genomic species (gen. sp.) 3, and Acinetobacter gen. sp. 13TU, which are included in the A. calcoaceticus-A. baumannii complex, are difficult to distinguish by phenotypic methods. An array with six oligonucleotide probes based on the 16S-23S rRNA gene intergenic spacer (ITS) region was developed to differentiate species in the A. calcoaceticus-A. baumannii complex. Validation of the array with a reference collection of 52 strains of the A. calcoaceticus-A. baumannii complex and 137 strains of other species resulted in an identification sensitivity and specificity of 100%. By using the array, the species distribution of 291 isolates of the A. calcoaceticus-A. baumannii complex from patients with bacteremia were determined to be A. baumannii (221 strains [75.9%]), Acinetobacter gen. sp. 3 (67 strains [23.0%]), Acinetobacter gen. sp. 13TU (2 strains [0.7%]), and unidentified Acinetobacter sp. (1 strain [0.3%]). The identification accuracy of the array for 12 randomly selected isolates from patients with bacteremia was further confirmed by sequence analyses of the ITS region and the 16S rRNA gene. Antimicrobial susceptibility testing of the 291 isolates from patients with bacteremia revealed that A. baumannii strains were less susceptible to antimicrobial agents than Acinetobacter gen. sp. 3. All Acinetobacter gen. sp. 3 strains were susceptible to ampicillin-sulbactam, imipenem, and meropenem; but only 67.4%, 90%, and 86% of the A. baumannii strains were susceptible to ampicillin-sulbactam, imipenem, and meropenem, respectively. The observed significant variations in antimicrobial susceptibility among different species in the A. calcoaceticus-A. baumannii complex emphasize that the differentiation of species within the complex is relevant from a clinical-epidemiological point of view.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385442      PMCID: PMC2446839          DOI: 10.1128/JCM.00014-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region.

Authors:  Chao Chien Chen; Lee Jene Teng; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 2.  Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

Authors:  John E McGowan
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

3.  Reliability of phenotypic tests for identification of Acinetobacter species.

Authors:  P Gerner-Smidt; I Tjernberg; J Ursing
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

4.  The addition of low numbers of 3' thymine bases can be used to improve the hybridization signal of oligonucleotides for use within arrays on nylon supports.

Authors:  T J Brown; R M Anthony
Journal:  J Microbiol Methods       Date:  2000-10       Impact factor: 2.363

5.  Antimicrobial susceptibility of Acinetobacter species.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Authors:  P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis.

Authors:  M Vaneechoutte; L Dijkshoorn; I Tjernberg; A Elaichouni; P de Vos; G Claeys; G Verschraegen
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Identification and biotyping of clinical isolates of Acinetobacter.

Authors:  P J Bouvet; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

9.  Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Authors:  P Gerner-Smidt; I Tjernberg
Journal:  APMIS       Date:  1993-11       Impact factor: 3.205

10.  Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp.

Authors:  Elizabeth T S Houang; Yiu Wai Chu; K Y Chu; K C Ng; C M Leung; A F B Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  9 in total

1.  Identification of clinically important anaerobic bacteria by an oligonucleotide array.

Authors:  Yu Tzu Lin; Mario Vaneechoutte; Ay Huey Huang; Lee Jene Teng; Hung-Mo Chen; Shu-Li Su; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

2.  Recurrent bacteremia caused by the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Authors:  Chih-Cheng Lai; Han-Lin Hsu; Che-Kim Tan; Hsih-Yeh Tsai; Aristine Cheng; Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Wang-Huei Sheng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

3.  Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.

Authors:  Hongjiang Yang; Li Liang; Shuxiang Lin; Shiru Jia
Journal:  BMC Microbiol       Date:  2010-04-29       Impact factor: 3.605

4.  Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex from various clinical specimens.

Authors:  Ni Tien; Bang-Jau You; Hui-Lan Chang; Hsiu-Shen Lin; Chin-Yi Lee; Tung-Ching Chung; Jang-Jih Lu; Chao-Chin Chang
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

5.  Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.

Authors:  Margaret A Fitzpatrick; Egon Ozer; Maureen K Bolon; Alan R Hauser
Journal:  J Infect       Date:  2014-09-19       Impact factor: 6.072

6.  Epidemiological characterizations of class 1 integrons from multidrug-resistant acinetobacter isolates in Daejeon, Korea.

Authors:  Ji Youn Sung; Sun Hoe Koo; Semi Kim; Kye Chul Kwon
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

7.  Insertions or deletions (Indels) in the rrn 16S-23S rRNA gene internal transcribed spacer region (ITS) compromise the typing and identification of strains within the Acinetobacter calcoaceticus-baumannii (Acb) complex and closely related members.

Authors:  Christopher Maslunka; Bianca Gifford; Joseph Tucci; Volker Gürtler; Robert J Seviour
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

8.  A Genomic Approach to Investigating Ocular Surface Microorganisms: Monitoring Core Microbiota on Eyelid Margin with a Dot hybridization Assay.

Authors:  Ming-Tse Kuo; Tsai-Ling Chao; Shu-Fang Kuo; Chun-Chih Chien; Alexander Chen; Yu-Hsuan Lai; Yu-Ting Huang
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

9.  Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis.

Authors:  Yolande Hauck; Charles Soler; Patrick Jault; Audrey Mérens; Patrick Gérome; Christine Mac Nab; François Trueba; Laurent Bargues; Hoang Vu Thien; Gilles Vergnaud; Christine Pourcel
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.